Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | U8265AA | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 2 | LN4932 | IM / LL |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 3Z34X | PO / MO |
Admitted to pediatric ICU early August 2025 with hyponatremic dehydration. MRI with concern for multiple associated short segment enteroenteric intussusceptions. Subsequent US without intussusception. Also severe hypoalbuminemia, hypogammaglobulinemia. Change in stool started prior to rotavirus vaccine.
Loose stool
Simethicone
NKDA
8/2/25 Sodium 117 meq/L, albumin 1.1 g/dL. 8/4/25 Extended stool pathogen molecular test negative. 8/4/25 Stool rotavirus antigen negative. 8/4/25 MRI chest/abd/pelvis report "IMPRESSION: Diffuse thickening of small bowel and colonic walls, suggesting enterocolitis. Multiple associated short segment enteroenteric intussusceptions. No mass or lymphatic malformation. Moderate ascites and bilateral pleural effusions." 8/6 IgG <40 mg/dL.